DrugDashboards

Fentanyl

Fentanyl · FENTANYL 25 ug/h · Patch · Transdermal · Mylan Pharmaceuticals Inc.

NDC 00378-9121-98 · 5 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 72 h in 1 PATCH · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $5.83 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$5.83per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$11.10per dosage unitgross, before rebates — matched by drug name · 2024
  • Part D point of sale (median)$6.67per unitnegotiated price across 5,496 plans — before rebates · Apr 1, 2026
  • Federal contracts pay (FSS)$1.29per unitMylan Pharmaceuticals, Inc. · Jan 1, 202322% of what pharmacies pay — a deeper discount than 95% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$5.83per TDPweighted avg manufacturer price $2.2876 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

All Part D pricing →
ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$6.67per unit
middle half $5.86$8.40 · 5,496 plans · Apr 1, 2026
Est. net of rebates
≈ $6.67
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 4 · prior auth 48% · step therapy 0% · qty limit 96%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 1 quarter since 2024.

NADAC price per unit

$0$2.00$4.00$6.00Nov 2013Sep 2026$5.83
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$35.65
Reported to Texas DSHS · 2026 annual filing · Mylan Pharmaceuticals Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$515,063
10,001 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for fentanyl (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier · median tier 4 across plans
  • Costs ≥ $950/fill · avg $112.51 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA076258
TE code
AB
Approval date
Jan 28, 2005
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fentanyl (Patch)

LabelerStrengthFirst seenLast seen
AlvogenFENTANYL 12.5 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 25 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 75 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 50 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 100 ug/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 50 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 62.5 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 75 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 87.5 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 100 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 12 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 25 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 37.5 ug/hJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fentanyl — NDC 00378-9121-98," retrieved September 3, 2026, https://drugdashboards.com/drug/00378912198.

Free to cite with attribution — see how the data is put together.